JPH06219933A - Method for decomposing melanin and decomposable substance of melanin - Google Patents
Method for decomposing melanin and decomposable substance of melaninInfo
- Publication number
- JPH06219933A JPH06219933A JP3197264A JP19726491A JPH06219933A JP H06219933 A JPH06219933 A JP H06219933A JP 3197264 A JP3197264 A JP 3197264A JP 19726491 A JP19726491 A JP 19726491A JP H06219933 A JPH06219933 A JP H06219933A
- Authority
- JP
- Japan
- Prior art keywords
- melanin
- degrading
- nitrogen
- culture
- basidiomycete
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 title claims abstract description 124
- 238000000034 method Methods 0.000 title claims description 14
- 239000000126 substance Substances 0.000 title claims description 14
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 24
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 12
- 239000002537 cosmetic Substances 0.000 claims abstract description 9
- 239000002243 precursor Substances 0.000 claims abstract description 6
- 241000221198 Basidiomycota Species 0.000 claims description 18
- 239000004480 active ingredient Substances 0.000 claims description 16
- 230000000593 degrading effect Effects 0.000 claims description 16
- 230000002087 whitening effect Effects 0.000 claims description 11
- 238000012258 culturing Methods 0.000 claims description 5
- 239000008103 glucose Substances 0.000 abstract description 16
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 13
- 244000005700 microbiome Species 0.000 abstract description 11
- 241000233866 Fungi Species 0.000 abstract description 6
- 238000000338 in vitro Methods 0.000 abstract description 6
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 238000006243 chemical reaction Methods 0.000 abstract description 4
- 239000001963 growth medium Substances 0.000 abstract description 4
- 238000001727 in vivo Methods 0.000 abstract description 3
- 230000000813 microbial effect Effects 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract 2
- 241000213810 Ephelis Species 0.000 abstract 1
- 229920000877 Melamine resin Polymers 0.000 abstract 1
- JDSHMPZPIAZGSV-UHFFFAOYSA-N melamine Chemical compound NC1=NC(N)=NC(N)=N1 JDSHMPZPIAZGSV-UHFFFAOYSA-N 0.000 abstract 1
- 208000003351 Melanosis Diseases 0.000 description 20
- 206010014970 Ephelides Diseases 0.000 description 18
- 239000002609 medium Substances 0.000 description 17
- 239000003921 oil Substances 0.000 description 12
- 229940060184 oil ingredients Drugs 0.000 description 12
- 239000003795 chemical substances by application Substances 0.000 description 9
- 229920001817 Agar Polymers 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 239000008272 agar Substances 0.000 description 8
- 239000012071 phase Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000000203 mixture Substances 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- 239000000839 emulsion Substances 0.000 description 6
- 210000003491 skin Anatomy 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000006210 lotion Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000003755 preservative agent Substances 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 241000238366 Cephalopoda Species 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 235000002595 Solanum tuberosum Nutrition 0.000 description 3
- 244000061456 Solanum tuberosum Species 0.000 description 3
- 102000003425 Tyrosinase Human genes 0.000 description 3
- 108060008724 Tyrosinase Proteins 0.000 description 3
- 239000013040 bath agent Substances 0.000 description 3
- 238000004042 decolorization Methods 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 230000008099 melanin synthesis Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 239000007854 depigmenting agent Substances 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 239000010696 ester oil Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 210000002752 melanocyte Anatomy 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 238000006395 oxidase reaction Methods 0.000 description 2
- -1 packs Substances 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 239000002884 skin cream Substances 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- WYVMDJWLFVQZAL-UHFFFAOYSA-N 4-propan-2-ylbenzene-1,2-diol Chemical compound CC(C)C1=CC=C(O)C(O)=C1 WYVMDJWLFVQZAL-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- AHMIDUVKSGCHAU-UHFFFAOYSA-N Dopaquinone Natural products OC(=O)C(N)CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- AHMIDUVKSGCHAU-LURJTMIESA-N L-dopaquinone Chemical compound [O-]C(=O)[C@@H]([NH3+])CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-LURJTMIESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 229940127408 Melanin Synthesis Inhibitors Drugs 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 241000186359 Mycobacterium Species 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000070196 Scirpus pendulus Species 0.000 description 1
- 239000004902 Softening Agent Substances 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 241000950638 Symphysodon discus Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010047642 Vitiligo Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 229940092738 beeswax Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- HOQADATXFBOEGG-UHFFFAOYSA-N isofenphos Chemical compound CCOP(=S)(NC(C)C)OC1=CC=CC=C1C(=O)OC(C)C HOQADATXFBOEGG-UHFFFAOYSA-N 0.000 description 1
- 239000007951 isotonicity adjuster Substances 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 231100000225 lethality Toxicity 0.000 description 1
- 210000002780 melanosome Anatomy 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 229960000990 monobenzone Drugs 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 229940056211 paraffin Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 210000004694 pigment cell Anatomy 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000001965 potato dextrose agar Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 1
- 229960001755 resorcinol Drugs 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、微生物、特にメラニン
分解性を有する担子菌を利用するメラニン分解方法、メ
ラニン分解性物質、及び美白化粧料に関するものであ
る。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a melanin-decomposing method, a melanin-decomposing substance and a whitening cosmetic composition which utilize microorganisms, especially basidiomycetes having a melanin-decomposing property.
【0002】[0002]
【従来の技術】メラニンは、皮膚の他に、中枢神経や網
膜でも生合成され、また動物に限らず、植物から微生物
に至るまで自然界に広く分布存在している。メラニン
は、チロシンがチロシナーゼの作用によりドーパ、更に
ドーパキノンへと変換され、次いで酸化が進んでインド
ール−5,6−ジヒドロキノンとなり、これが重合して
生成するものである(参考文献1)。BACKGROUND OF THE INVENTION Melanin is biosynthesized not only in the skin but also in the central nerves and retina, and is widely distributed not only in animals but also in plants and microorganisms in nature. Melanin is produced by the conversion of tyrosine into dopa and further dopaquinone by the action of tyrosinase, followed by oxidation to become indole-5,6-dihydroquinone, which is polymerized (reference document 1).
【0003】メラニンの生合成は、紫外線をトリガーの
ひとつとして、表皮の基底層に存在する細胞、メラノサ
イトで行われる(参考文献2)。メラノサイトでは、メ
ラノソームと呼ばれる顆粒中でメラニンが合成、成熟さ
れて表皮細胞に移動、分散し、皮膚の代謝に伴って退色
し、更新の際に垢となって脱落する(参考文献3)。こ
のように、メラニンは紫外線の悪影響から身体を守る重
要な役目を担っており、医学上重要な因子である。しか
しながら、メラニン量が多くなると色黒の皮膚となる
し、また、その不均一な分布は、シミ(肝斑)、ソバカ
ス(雀卵斑)となって美容上大きな問題となる。The biosynthesis of melanin is carried out by melanocytes, which are cells located in the basal layer of the epidermis, using ultraviolet light as one of the triggers (reference document 2). In melanocytes, melanin is synthesized and matured in granules called melanosomes, migrates and disperses in epidermal cells, discolors with the metabolism of the skin, and becomes dross and falls off during renewal (Reference 3). Thus, melanin plays an important role in protecting the body from the adverse effects of ultraviolet rays, and is an important factor in medicine. However, when the amount of melanin increases, the skin becomes darker, and the uneven distribution thereof causes spots (melasma) and freckles (mottled freckles), which is a serious cosmetic problem.
【0004】現在知られているシミ、ソバカス対策は、
2つの予防法と1つの治療法に大別される。The currently known measures against spots and freckles are:
It is roughly divided into two preventive methods and one therapeutic method.
【0005】予防法には、(1)メラニン生合成の引金
となるUV光をサンスクリーン剤等で遮光する方法(参
考文献6)と、(2)メラニン生合成を阻害する薬品
(例えば、グルタチオン、ビタミンC、システイン、ア
ルブチン、チオ硫酸ソーダといったメラニン合成阻害剤
等)を用いる方法(参考文献7、8)とが知られてい
る。Preventive measures include (1) a method of blocking UV light that triggers melanin biosynthesis with a sunscreen agent or the like (reference document 6), and (2) a drug that inhibits melanin biosynthesis (for example, A method using melanin synthesis inhibitors such as glutathione, vitamin C, cysteine, arbutin, and sodium thiosulfate) (References 7 and 8) is known.
【0006】しかしながら、一旦形成されてしまったシ
ミ、ソバカスを治療消失せしめるための副作用のない安
全な方法は未だ開発されていないのが現状である(参考
文献2、4)。以前、ハイドロキノン、4−イソプロピ
ルカテコール、ハイドロキノンモノベンジルエーテルが
皮膚漂白剤として用いられたこともあったが、これらは
強力な美白作用を有するものの、それは色素細胞の変
性、致死に基づくものである故、外用を継続すると永久
的白斑となる可能性があり、その他色素異常、かぶれ等
の副作用も避けられないため、現在は市販されておら
ず、当業界においては安全なシミ、ソバカス治療剤の開
発が強く望まれている(参考文献5)。However, the present situation is that a safe method for eliminating the stains and freckles once formed by treatment has no side effect has been developed (References 2 and 4). Previously, hydroquinone, 4-isopropylcatechol, and hydroquinone monobenzyl ether were also used as skin bleaching agents, but they have a strong whitening effect, but they are based on degeneration and lethality of pigment cells. , Continued topical application may cause permanent vitiligo, and other side effects such as pigment abnormalities and rashes are unavoidable, so it is not currently on the market and the development of safe spots and freckles treatment agents in the industry Is strongly desired (reference 5).
【0007】したがって現在のところ、シミ、ソバカス
の治療法としては、メラニンが表皮の更新に伴って脱落
する期間を、レゾルシンやサリチル酸といった角質の軟
化、剥離剤を用いて短縮する方法が知られているにすぎ
ない(参考文献4)。しかしながらこの方法は、本来、
シミ、ソバカスの治療法といえるものでないし、治療す
るのに数ヶ月間という長期間を要し、現実的な治療法と
はいい得ない。[0007] Therefore, at present, as a method for treating spots and freckles, a method of shortening the period during which melanin is removed due to renewal of the epidermis by using keratin softening agents such as resorcin and salicylic acid, and a peeling agent is known. (Reference 4). However, this method originally
It is not a cure for spots and freckles, and it takes a long time of several months to treat, so it cannot be called a realistic cure.
【0008】〔参考文献〕 1.蛋白質・核酸・酵素、15、p.550(197
0) 2.福代良一外「皮膚科診断治療大系4」講談社、p.
38 3.細胞、4、(9)、p.16(1972) 4.宮崎順一「皮膚外用剤 その作り方と応用」南山
堂、p.273−275、353−355 5.臨皮、44、(6)、p.629(1990) 6.化粧品科学研究会「最新化粧品科学」薬時日報社、
(昭61−4−15)、p.391−395 7.特開昭53−142515号公報 8.特開昭48−44442号公報[References] 1. Protein / nucleic acid / enzyme, 15, p. 550 (197
0) 2. Ryoichi Fukushiro, "Dermatological Diagnosis and Treatment Type 4" Kodansha, p.
38 3. Cells, 4, (9), p. 16 (1972) 4. Junichi Miyazaki, “External preparation for skin, its preparation and application”, Nanzandou, p. 273-275, 353-355 5. Lin, 44, (6), p. 629 (1990) 6. Cosmetic Science Study Group "Latest Cosmetic Science"
(Sho 61-4-15), p. 391-395 7. JP-A-53-142515 JP-A-48-44442
【0009】[0009]
【発明が解決しようとする課題】本発明は、このような
技術の現状に鑑みてなされたものであって、シミ、ソバ
カスの生成を予防するのではなく、従来開発するのに成
功できなかった生成されたシミ、ソバカスを安全に治療
するための新規システムを開発する目的でなされたもの
である。SUMMARY OF THE INVENTION The present invention has been made in view of the current state of the art, and has not been successful in the conventional development, rather than preventing the generation of spots and freckles. It was made for the purpose of developing a new system for safely treating the generated spots and freckles.
【0010】また、シミ、ソバカスの主因がメラニンに
あることから、メラニンは皮膚以外にも各種の着色製品
等生体外物質にも含まれており、これらの脱色も業界に
おいて強く要望されている点も考慮に入れ、in vi
vo及びin vitroでもメラニンを分解できる新
規システムを開発する目的でも、本発明はなされたもの
である。Since the main cause of spots and freckles is melanin, melanin is also contained in in vitro substances such as various colored products in addition to the skin, and decolorization thereof is also strongly demanded in the industry. Taking into account
The present invention has been made for the purpose of developing a new system capable of degrading melanin in vo and in vitro.
【0011】[0011]
【課題を解決するための手段】上記目的を達成するため
に各方面から検討の結果、安全性の面から生物処理に着
目し、微生物について鋭意スクリーニングを行ったが結
局成功するに至らず、そこで発想を転換してメラニンの
分解とは全く関連性のない木材腐朽菌にはじめて着目し
た。[Means for Solving the Problems] In order to achieve the above-mentioned object, as a result of examinations from various aspects, attention was paid to biological treatment from the viewpoint of safety, and intensive screening was conducted for microorganisms, but it did not succeed in the end, and there For the first time, I changed my mind and focused on wood-destroying fungi that had nothing to do with the degradation of melanin.
【0012】そして木材腐朽菌の中から、メラニン分解
性を有する微生物をスクリーニングするのに成功し、遂
に本発明の完成に至ったものであって、本発明は、メラ
ニン分解性を有する担子菌の培養物又はその処理物を用
いてメラニンを分解する点を基本的技術思想として新規
に採用したものである。The present invention succeeded in screening a microorganism capable of degrading melanin from wood-destroying fungi, and finally completed the present invention. The present invention provides a basidiomycete having melanin degradability. It is a new technical idea to decompose melanin using a culture or a treated product thereof as a basic technical idea.
【0013】本発明において使用可能な微生物は、メラ
ニン分解性を有する木材腐朽菌であれば、白色(リグニ
ン分解菌等)、褐色を問わずすべての木材腐朽菌が使用
可能であり、例えば、NK−1148株(FERM B
P−1859)、あるいはポロディスキュラス(Por
odisculus)属に属する微生物等が有利に利用
できる。Microorganisms that can be used in the present invention include all wood-decaying fungi, regardless of whether they are white (lignin-decomposing fungi) or brown, as long as they are wood-decaying fungi having melanin decomposing property. -1148 strain (FERM B
P-1859) or Polo discus (Por
Microorganisms belonging to the genus Odisculus) can be advantageously used.
【0014】NK−1148株は、本発明者らによって
分離された微生物であって、すぐれたメラニン分解菌で
あり、その菌学的性質については特公平3−32996
号公報に詳記されているが、その主なものは次のとおり
である。The NK-1148 strain is a microorganism isolated by the present inventors and is an excellent melanin-degrading bacterium, and its mycological properties are described in JP-B-3-32996.
The details are as follows, but the main ones are as follows.
【0015】〔(1)培地における生育状態〕下記する
表1に示すとおりである。[(1) Growth state in culture medium] As shown in Table 1 below.
【0016】[0016]
【表1】 [Table 1]
【0017】〔(2)生理的、生態的性質〕 生育のpH範囲(バレイショ・ブドウ糖寒天培地、2
8℃、4日間培養) pH3〜9付近で生育し、pH2および10では生育し
ない。最適pHは4〜6付近である。 生育の温度範囲(バレイショ・ブドウ糖寒天培地、p
H5、4日間培養) 10〜45℃付近で生育し、50℃では生育しない。最
適温度は28〜37℃付近である。 フェノールオキシダーゼ反応(28℃、4日間培養) 微弱または陰性を示す。 菌そうの特徴(バレイショ・ブドウ糖寒天培地、pH
5、28℃、4日間培養) 白色でフェルト状である。[(2) Physiological and ecological properties] pH range of growth (potato-glucose agar medium, 2
Cultivated at 8 ° C. for 4 days) Grows at around pH 3 to 9, but not at pH 2 and 10. The optimum pH is around 4-6. Growth temperature range (potato-glucose agar, p
H5, 4 days culture) Grows at around 10 to 45 ° C, but does not grow at 50 ° C. The optimum temperature is around 28 to 37 ° C. Phenol oxidase reaction (28 ° C, 4 days culture) Shows weak or negative. Characteristics of mycobacterium (potato, glucose agar, pH
5, 28 ° C., 4 days culture) White and felt-like.
【0018】これらの生理的、生態的性質及び各培地に
おける生育状態といった菌学的性質を詳細に検討した
が、既知の菌と同定するには至らなかった。そこで、本
菌株を新菌株と同定し、NK−1148株と命名してこ
れを微工研へ寄託した(FERM BP−1859)。The physiological and ecological properties and the mycological properties such as the growth state in each medium were examined in detail, but it could not be identified as a known bacterium. Therefore, this strain was identified as a new strain, named as NK-1148 strain, and deposited at Micro Engineering Laboratories (FERM BP-1859).
【0019】ポロディスキュラス属菌としては、例えば
本発明者らが新たに分離するのに成功したヌルデタケ
(Porodisculus pendulus)に属
する菌株NK−729W(FERM BP−1860)
が例示される。本菌株は、メラニンを高度に分解するこ
とができ非常にすぐれており、その菌学的性質について
は特公平3−32997号公報に詳記されているが、そ
の主なものは次のとおりである。Examples of the bacterium belonging to the genus Porodiscus include, for example, a strain NK-729W (FERM BP-1860) belonging to Nurudetake (Porodiscus pendulus) which the present inventors succeeded in newly separating.
Is exemplified. This strain is extremely excellent in that it can highly decompose melanin, and its mycological properties are described in detail in JP-B-3-32997, the main ones of which are as follows. is there.
【0020】〔(1)培地における生育状態〕下記する
表2に示すとおりである。[(1) Growth state in culture medium] As shown in Table 2 below.
【0021】[0021]
【表2】 [Table 2]
【0022】〔(2)生理的、生態的性質〕 生育のpH範囲(バレイショ・ブドウ糖寒天培地、2
8℃、培養4日間) pH3〜7付近で生育し、pH2および8では生育しな
い。最適pHは4〜5付近である。 生育の温度範囲(バレイショ・ブドウ糖寒天培地、p
H5、培養4日間) 10〜32℃付近で生育し、37℃では生育しない。最
適温度は20〜30℃付近である。 フェノールオキシダーゼ反応(28℃、培養4日間) 陽性を示す。 菌そうの形状(バレイショ・ブドウ糖寒天培地、pH
5、28℃、培養4日間) 白色で毛状である。 子実体の形状 ・大きさ:径2〜5mm ・形:倒椀形(鼻の形) ・縁や表面:縁は内側へ巻き、表面は黄褐色で全面に褐
色毛がある。 ・管孔面:淡灰白色で倒皿状にへこんでおり管孔は小さ
い。 ・肉質:柔軟な革質でほぼ白色である。 胞子の形状 3〜4×1μm程度のソーセージ形で無色平滑である。[(2) Physiological and ecological properties] Growth pH range (potato-glucose agar medium, 2
8 ° C, 4 days of culture) Grows at around pH 3 to 7, but not at pH 2 and 8. The optimum pH is around 4-5. Growth temperature range (potato-glucose agar, p
H5, 4 days of culture) Grows at around 10 to 32 ° C, not at 37 ° C. The optimum temperature is around 20 to 30 ° C. Phenol oxidase reaction (28 ° C, 4 days of culture) shows positive. Bacterial shape (potato, glucose agar, pH
5, 28 ° C, 4 days of culture) White and hairy. Shape of fruiting body ・ Size: Diameter 2-5mm ・ Shape: Inverted bowl shape (shape of nose) ・ Rim and surface: Edge curls inward, surface is yellowish brown with brown hair on the entire surface.・ Pipe hole surface: Light grayish white, dented like a dish, and the hole is small. -Meat quality: It is a soft leather and almost white. Spore shape Sausage shape of about 3 to 4 × 1 μm, which is colorless and smooth.
【0023】これらの菌学的性質からして、本菌は、ポ
ロディスキュラス属に属するものと認められ、分類学
上、特にその内のヌルデタケ(Porodisculu
s pendulus)に属せしめるのが適当であると
認められる。Based on these mycological characteristics, the present bacterium is recognized as belonging to the genus Porodiscus, and taxonomically, especially, P.
S. pendulus) is considered appropriate.
【0024】本発明においては、メラニン分解性を有す
る担子菌を使用するのであるが、菌自体のほか、その培
養物及び/又はその処理物も使用することができる。該
培養物とは、菌を培養して得た菌体及び培養液の混合物
を広く指すが、本発明においては、菌体培養物から分離
したウェットケーキ等の菌体、その残渣、及び、固体物
をすべて除去した後の培養液を利用することもできる。
また、その処理物とは、上記したものを濃縮、乾燥、ま
たは希釈したものをすべて指すものである。In the present invention, a basidiomycete having a melanin degrading property is used, but in addition to the bacterium itself, a culture product and / or a processed product thereof can also be used. The culture broadly refers to a mixture of cells and a culture solution obtained by culturing a bacterium, but in the present invention, cells such as wet cake separated from the cell culture, its residue, and solids. It is also possible to use the culture medium after removing all the substances.
In addition, the processed product refers to all of the above-mentioned products that have been concentrated, dried, or diluted.
【0025】本発明にしたがってメラニンを分解するに
は、メラニン分解性を有する担子菌の菌体、培養物及び
/又は処理物をメラニンとin vivo又はin v
itroで接触せしめればよく、その際場合によっては
10〜45℃付近で所要時間インキューベートしてもよ
い。なおメラニンとの接触時に、反応系は窒素を制限し
た状態におくのが好適であって、窒素源は皆無ないし可
及的少量とした条件下とするのが好ましい。そしてこの
際、グルコースを併用すると更に有効である。In order to decompose melanin according to the present invention, the microbial cells, cultures and / or processed products of basidiomycetes having melanin-degrading property are treated with melanin in vivo or in v.
It may be contacted in vitro, and in that case, it may be incubated at about 10 to 45 ° C. for the required time. During the contact with melanin, the reaction system is preferably kept in a nitrogen-restricted state, and it is preferable that the nitrogen source is not present or the amount is as small as possible. At this time, it is more effective to use glucose together.
【0026】したがって本発明に係るメラニン分解性物
質は、メラニン分解性を有する担子菌の菌体、培養物及
び/又は処理物を有効成分としてこれに常用される無機
又は有機の担体を加えて、固体、半固体又は液体の形
で、経口投与剤のほか、外用剤や浴剤等の非経口投与剤
に製剤化すればよいが、工業用に使用する場合は有効成
分のみでもよい。Therefore, the melanin-degrading substance according to the present invention comprises a basidiomycete fungus having melanin-decomposing property, a culture and / or a treated product as an active ingredient, and an inorganic or organic carrier commonly used therein, In solid, semi-solid or liquid form, it may be formulated into an oral administration agent as well as a parenteral administration agent such as an external preparation or a bath agent, but in the case of industrial use, it may contain only the active ingredient.
【0027】経口投与のための製剤としては、錠剤、丸
剤、顆粒剤、軟・硬カプセル剤、散剤、細粒剤、粉剤、
乳濁剤、懸濁剤、シロップ剤、エリキシル剤等が挙げら
れる。非経口投与のための製剤としては、注射剤、軟
膏、ローション、トニック、スプレー、懸濁剤、油剤、
乳剤、坐剤等が挙げられる。本発明の有効成分を製剤化
するには、常法にしたがえばよく、界面活性剤、賦形
剤、着色料、着香料、保存料、安定剤、緩衝剤、懸濁
剤、等張剤その他常用される物質を適宜使用する。The preparations for oral administration include tablets, pills, granules, soft and hard capsules, powders, fine granules, powders,
Emulsifiers, suspensions, syrups, elixirs and the like can be mentioned. Formulations for parenteral administration include injections, ointments, lotions, tonics, sprays, suspensions, oils,
Examples thereof include emulsions and suppositories. In order to formulate the active ingredient of the present invention, conventional methods may be followed, including surfactants, excipients, coloring agents, flavoring agents, preservatives, stabilizers, buffers, suspending agents, isotonic agents. Other commonly used substances are used as appropriate.
【0028】本発明に係る物質は、シミ、ソバカスの程
度、投与方法、年令等によってその投与量は相違する
が、経口ないし経腸投与の場合は成人ひとり当り1日に
有効成分を0.1〜100mg/kgの範囲内で投与す
る。皮膚外用剤として投与する場合には、適量を患部に
数回適用すればよい。工業的応用の場合には上記のよう
な格別の限定はなく、該物質とメラニン除去対象とを適
宜接触せしめればよい。なお、本物質をラットに対して
体重1kg当り100mg経口投与したが、格別の毒性
は認められず安全であった。The dose of the substance according to the present invention varies depending on the degree of spots, freckles, administration method, age and the like, but in the case of oral or enteral administration, the active ingredient is 0.1% per adult per day. It is administered within the range of 1 to 100 mg / kg. When administered as an external preparation for skin, an appropriate amount may be applied to the affected area several times. In the case of industrial application, there is no particular limitation as described above, and the substance and the melanin removal target may be brought into contact with each other as appropriate. The substance was orally administered to rats at a dose of 100 mg / kg of body weight, but no toxicity was observed and it was safe.
【0029】また本発明は、メラニン分解性を有する担
子菌の菌体、培養物及び/又は処理物を有効成分とする
美白化粧料に関するものであるが、本発明の美白化粧料
は主として化粧水、クリーム、乳液、パック、浴剤、毛
髪脱色剤などの皮膚外用剤であり、それらの各外用剤に
通常に使用される外用基剤、助剤などに上記有効成分を
0.001〜15%好ましくは0.01〜10%配合し
て外用剤とする。The present invention also relates to a whitening cosmetic composition containing a melanin-degrading basidiomycete fungus body, a culture and / or a treated product as an active ingredient. The whitening cosmetic composition of the present invention is mainly a lotion. , Creams, emulsions, packs, bath agents, hair depigmenting agents and the like, and the above-mentioned active ingredient is contained in 0.001 to 15% in the external bases and auxiliaries usually used for each of these external preparations. Preferably, 0.01 to 10% is blended to obtain an external preparation.
【0030】例えば、化粧水においては、精製水にグリ
セリン、プロピレングリコールなどの保湿剤、皮膚栄養
剤などを溶解し、防腐剤、香料などをアルコールに溶解
し、両者を混合して室温下に可溶化する一般の化粧水の
製造において、水溶部に本発明の有効成分を0.01〜
10%になるように加えて化粧水とする。For example, in the case of lotion, moisturizers such as glycerin and propylene glycol, skin nutrients, etc. are dissolved in purified water, preservatives, fragrances, etc. are dissolved in alcohol, and both are mixed at room temperature. In the production of a general lotion to be solubilized, the active ingredient of the present invention is added in an amount of 0.01 to
Add to 10% to make up lotion.
【0031】クリームにおいては、精製水に親水性成分
例えばグリセリン、ソルビットなどの保湿剤を添加して
水相部とし、油相部はミツロウ、パラフィン、マイクロ
クリスタリンワックス、セレシン、高級脂肪酸、硬化油
などの固形油分、それにスクワラン、流動パラフィン、
各種エステル油などの液状油分に防腐剤、界面活性剤な
どの油性成分を添加し調製する。このようにして得られ
た水相部を加温して、ゆるやかに攪拌しつつ同温度に加
温された油相部を徐々に添加して乳化クリームとする一
般のクリームの製造において、水相部に有効成分を0.
01〜10%になるように加えてクリームとする。In the cream, a hydrophilic component such as glycerin or sorbit is added to purified water to form a water phase part, and an oil phase part is beeswax, paraffin, microcrystalline wax, ceresin, higher fatty acid, hardened oil, etc. Solid oil, plus squalane, liquid paraffin,
It is prepared by adding oil components such as preservatives and surfactants to liquid oil components such as various ester oils. The water phase obtained in this manner is heated, and in the production of a general cream to be an emulsified cream by gradually adding the oil phase heated to the same temperature while gently stirring, The active ingredient in 0.
Add to make it 10 to 10% to make a cream.
【0032】乳液においては、精製水にグリセリンなど
の保湿剤、酸又はアルカリのpH調整剤などを加え加熱
混合してエタノールを加え水相部とし、ミツロウ、パラ
フィンなどの固形油分、ワセリン、ラノリンなどの半固
形油分、スクワラン、流動パラフィン、各種エステル油
などの液状油分に、防腐剤、界面活性剤などの油性成分
を添加調製して混合加熱し油相部とし、油相部を水相部
に加えて予備乳化を行い、これにカルボキシビニルポリ
マー、カルボキシメチルセルロースなどの保護コロイド
剤を加え、ホモミキサーで均一に乳化して乳液とする一
般の乳液の製造において、水相部に本発明の有効成分を
0.01〜10%になるように水相部に加えて乳液とす
る。In the emulsion, a moisturizing agent such as glycerin, a pH adjusting agent for an acid or an alkali is added to purified water, and the mixture is heated and mixed to add ethanol to form a water phase portion. Solid oil components such as beeswax and paraffin, petrolatum, lanolin, etc. Of semi-solid oil, liquid oil such as squalane, liquid paraffin, and various ester oils, and oil ingredients such as preservatives and surfactants are added and prepared, mixed and heated to form the oil phase, and the oil phase is converted to the water phase. In addition, preliminary emulsification is performed, and a protective colloid agent such as carboxyvinyl polymer and carboxymethyl cellulose is added to this, and in the production of a general emulsion to be uniformly emulsified with a homomixer, the active ingredient of the present invention in the aqueous phase part. Is added to the aqueous phase so as to be 0.01 to 10% to obtain an emulsion.
【0033】パックにおいては、精製水にグリセリンな
どの保湿剤、ポリビニルアルコール、ビーガムなどの皮
膜剤などを加えて膨潤させ、これに必要があればカオリ
ン、タルク、酸化亜鉛などの粉末を加え、香料、防腐剤
などを溶解したエタノールを加えてペースト状となるま
で混練する一般のパックの製造において、本発明の有効
成分を0.01〜10%になるように加えてパックとす
る。浴剤や毛髪脱色剤についても常法にしたがってこれ
を調製して何ら差し支えはない。In the pack, a moisturizing agent such as glycerin, a filming agent such as polyvinyl alcohol or bee gum is added to purified water to swell, and powders of kaolin, talc, zinc oxide and the like are added thereto if necessary, and a fragrance is added. In the production of a general pack in which ethanol containing a preservative and the like is added and kneaded until it becomes a paste, the active ingredient of the present invention is added to 0.01 to 10% to form a pack. There is no problem in preparing a bath agent and a hair decolorizing agent according to a conventional method.
【0034】本発明を実施するに当り、メラニンとの接
触は窒素を制限した条件下で行うと好結果が得られるこ
とは既に述べたところであるが、その際メラニン分解性
を有する担子菌として、予じめ窒素制限条件下でメラニ
ン及び/又はその前駆体を存在せしめた培地で培養した
微生物を用いると更に良好な結果が得られる。メラニン
のプレカーサーとしては、既に述べたメラニンの生成に
至る各種の低分子、高分子化合物が適宜単用ないし併用
できる。In carrying out the present invention, it has already been described that the contact with melanin is carried out under the condition that nitrogen is restricted, and at this time, as a basidiomycete capable of degrading melanin, Even better results are obtained with microorganisms which have been cultivated in a medium in the presence of melanin and / or its precursors under pre-determined nitrogen-limited conditions. As the precursor for melanin, various low-molecular and high-molecular compounds which have already been mentioned can be used alone or in combination.
【0035】以下、本発明の実施例について述べる。Examples of the present invention will be described below.
【0036】[0036]
【実施例1】ポテトデキストロース寒天培地(グルコー
ス2%含有)、窒素を制限した合成培地(下記の表3に
示すL−N培地)にグルコースをそれぞれ0%、0.1
%、1%添加した培地、の計4種類の培地をペトリ皿に
用意した。これにメラニン試料として、ササイカの墨
(その約50%がメラニンからなる)を分散せしめた。Example 1 0% glucose and 0.1% glucose were added to a potato dextrose agar medium (containing 2% glucose) and a nitrogen-restricted synthetic medium (L-N medium shown in Table 3 below), respectively.
%, 1% added medium, a total of 4 types of medium were prepared in Petri dishes. As a melanin sample, sasaika ink (about 50% of which is melanin) was dispersed.
【0037】[0037]
【表3】 [Table 3]
【0038】一方、メラニン分解性を有する担子菌NK
−1148株(FERM BP−1859)を、上記ペ
トリ皿の縁部に接種し、28℃でインキューベートし
た。On the other hand, basidiomycete NK having melanin degrading property
Strain -1148 (FERM BP-1859) was inoculated on the edge of the Petri dish and incubated at 28 ° C.
【0039】その結果、NK−1148株はメラニンを
脱色ないし分解することができることが確認され、特に
窒素制限培地にグルコースを1%添加した場合(図1右
側のペトリ皿:N50G1、つまりイカスミ液50μl
/培地20ml、表3の培地でグルコース1%添加)、
最も速く現象が現われ、本発明の有効性が立証された。
菌糸の成長はポテトデキストロース培地が最も顕著であ
ったが、メラニンの脱色ないし分解は全く観察されなか
った。これらのことから、メラニンの分解に窒素制限が
有効であることが判った。また、グルコースを添加しな
かった場合、及び0.1%に制限した場合は、いずれも
菌糸の成長が旺盛でないにしろそれが観察されたにもか
かわらず、メラニンの脱色ないし分解は僅かであった。
これらのことから、メラニンの分解には糖が何らかの役
割を果していることが判った。As a result, it was confirmed that the strain NK-1148 was capable of decolorizing or degrading melanin, and particularly when 1% of glucose was added to the nitrogen-restricted medium (Petri dish on the right side of FIG. 1: N50G1, that is, Squid solution 50 μl).
/ Medium 20 ml, glucose 1% added in the medium of Table 3),
The phenomenon appeared fastest, demonstrating the effectiveness of the present invention.
The growth of hypha was most remarkable in the potato dextrose medium, but decolorization or decomposition of melanin was not observed at all. From these, it was found that nitrogen limitation is effective for the decomposition of melanin. Further, when glucose was not added or when it was limited to 0.1%, decolorization or decomposition of melanin was slight even though it was observed although the growth of mycelium was not strong. It was
From these, it was found that sugar plays some role in the degradation of melanin.
【0040】これらの結果から明らかなように、NK−
1148株が卓越したメラニン分解性を示すことが科学
的に立証された。As is clear from these results, NK-
It has been scientifically proven that strain 1148 exhibits excellent melanin degrading property.
【0041】[0041]
【実施例2】NK−1148株にかえてNK−729W
(FERM BP−1860)を用いたほかは実施例1
と同様の操作をくり返して、窒素制限下におけるメラニ
ンの分解性を同様にして確認した。Example 2 NK-729W in place of NK-1148 strain
Example 1 except using (FERM BP-1860)
By repeating the same operation as above, the degradability of melanin under nitrogen limitation was similarly confirmed.
【0042】[0042]
【実施例3:美白スキンクリーム】表3に示すL−N培
地から寒天を除いて、グルコース10g、イカスミ液2
mlを添加した液体培地で培養したNK−1148株の
培養物を用い、下記表4の処方にて、常法にしたがって
O/Wエマルジョンを調製し、シミ、ソバカス治療用の
スキンクリームを製造した。[Example 3: Whitening skin cream] Glucose 10 g, squid solution 2 were obtained by removing agar from the LN medium shown in Table 3.
Using a culture of the NK-1148 strain cultured in a liquid medium containing ml, an O / W emulsion was prepared according to a conventional method according to the formulation shown in Table 4 below to produce a skin cream for treating spots and freckles. .
【0043】[0043]
【表4】 [Table 4]
【0044】[0044]
【実施例4:美白パック剤】表3に示すL−N培地から
寒天を除いて、グルコース10g、イカスミ液2mlを
添加した液体培地で培養したNK−729W株の培養物
を用い、下記表5の処方において、常法にしたがって、
Aを混合溶解してゲルとなし、ついでB及びCを順次A
に添加して、シミ、ソバカス治療用のパック剤を製造し
た。[Example 4: Whitening pack] Using the culture of NK-729W strain, the agar was removed from the L-N medium shown in Table 3 and cultured in a liquid medium containing 10 g of glucose and 2 ml of Squid solution, and the following Table 5 was used. In the prescription of, according to the usual method,
A is mixed and dissolved to form a gel, and then B and C are sequentially A
To prepare a pack for treating spots and freckles.
【0045】[0045]
【表5】 [Table 5]
【0046】[0046]
【発明の効果】従来、シミ、ソバカス用の美白化粧料と
しては、シミ、ソバカスの生成を予防する製品しか開発
されておらず、一旦生成したシミ、ソバカスを消失、軽
減せしめる製品、つまり安全性の高いシミ、ソバカス治
療剤の開発には成功していない。As a whitening cosmetic for spots and freckles, only a product that prevents the formation of spots and freckles has been developed so far, and a product that eliminates or reduces the spots and freckles that have been once formed, that is, safety. It has not been successful in developing a therapeutic agent for freckles and freckles, which has a high level of stains.
【0047】これに対して本発明は、このように従来ど
うしても開発し得なかった安全性のきわめて高いシミ、
ソバカス治療剤の開発にはじめて成功したものである。
しかも本発明は、外用だけでなく内服しても有効性を発
揮するという著効も奏するものである。On the other hand, the present invention, as described above, is a highly safe stain which has never been developed by the conventional method.
It was the first successful development of a freckle remedy.
Moreover, the present invention has a remarkable effect that it is effective not only for external use but also for internal use.
【0048】本発明の作用は、卓越したメラニン分解作
用に基づくものであるが、この作用は上記のようにin
vivoのみでなくin vitroでも奏され、ま
た工業面においても利用することができる。例えば、各
種の着色製品等生体外物質にはメラニンが含まれている
が、これを本発明物質を用いて処理することによりメラ
ニンを分解して脱色することが可能となり、したがって
本発明によれば、メラニン由来の着色工業製品の脱色が
効率的に行えるという著効も奏される。The action of the present invention is based on the excellent melanin degrading action, which is as described above.
It is played not only in vivo but also in vitro, and can be used in industrial aspects. For example, in vitro substances such as various colored products contain melanin, but by treating it with the substance of the present invention, it becomes possible to decompose and decolorize melanin, and therefore, according to the present invention, The remarkable effect that the colored industrial products derived from melanin can be efficiently decolorized.
【図1】メラニン分解性を有する担子菌によるメラニン
分解能を示した写真である。(左側は、メラニン分解性
を有する担子菌無接種の対照である。右側のペトリ皿か
ら明らかなように、本発明によってメラニンが分解され
てメラニンの黒い部分が消失し、白色化しているのがわ
かる。)FIG. 1 is a photograph showing melanin-degrading ability of basidiomycetes having melanin-degrading properties. (The left side is a control without inoculation of basidiomycetes having melanin-degrading property. As is clear from the Petri dish on the right side, the melanin is decomposed by the present invention and the black part of melanin disappears, and whitening occurs. Recognize.)
Claims (9)
の培養物もしくはその処理物により、メラニンを分解す
ることを特徴とするメラニンの分解方法。1. A method for degrading melanin, which comprises degrading melanin with a basidiomycete fungus having melanin degrading property, a culture product thereof, or a treated product thereof.
せることを特徴とする請求項1のメラニンの分解方法。2. The method for degrading melanin according to claim 1, wherein the melanin is brought into contact with nitrogen in a state where nitrogen is limited.
る担子菌菌体、その培養物がメラニンもしくはその前駆
体を添加した培地で培養したものであることを特徴とす
るメラニンの分解方法。3. A method for decomposing melanin, characterized in that the basidiomycete fungus body having melanin degrading property according to claim 1, and the culture thereof are cultured in a medium to which melanin or a precursor thereof is added.
もしくはその処理物を有効成分とするメラニン分解性物
質。4. A melanin-degrading substance containing a basidiomycete culture having melanin-degrading property or a treated product thereof as an active ingredient.
制限した培地で培養した培養物もしくはその処理物を有
効成分とするメラニン分解性物質。5. A melanin-degrading substance containing a culture obtained by culturing a basidiomycete having melanin-degrading property in a medium restricted with nitrogen or a treated product thereof as an active ingredient.
ンもしくはその前駆体を添加した培地で培養した培養物
もしくはその処理物を有効成分とするメラニン分解性物
質。6. A melanin-degrading substance containing a culture product obtained by culturing a basidiomycete having melanin-degrading property in a medium to which melanin or a precursor thereof is added, or a treated product thereof as an active ingredient.
もしくはその処理物を有効成分とする美白化粧料。7. A whitening cosmetic comprising a basidiomycete culture having a melanin degrading property or a treated product thereof as an active ingredient.
制限した培地で培養した培養物もしくはその処理物を有
効成分とする美白化粧料。8. A whitening cosmetic comprising as an active ingredient a culture obtained by culturing a basidiomycete having melanin degrading ability in a medium in which nitrogen is restricted, or a treated product thereof.
ンもしくはその前駆体を添加した培地で培養した培養物
もしくはその処理物を有効成分とする美白化粧料。9. A whitening cosmetic comprising as an active ingredient a culture obtained by culturing a basidiomycete having melanin degrading ability in a medium containing melanin or a precursor thereof, or a treated product thereof.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3197264A JPH06219933A (en) | 1991-07-12 | 1991-07-12 | Method for decomposing melanin and decomposable substance of melanin |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3197264A JPH06219933A (en) | 1991-07-12 | 1991-07-12 | Method for decomposing melanin and decomposable substance of melanin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH06219933A true JPH06219933A (en) | 1994-08-09 |
Family
ID=16371583
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP3197264A Pending JPH06219933A (en) | 1991-07-12 | 1991-07-12 | Method for decomposing melanin and decomposable substance of melanin |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH06219933A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU667338B2 (en) * | 1993-02-08 | 1996-03-21 | Kabushiki Kaisha Kobe Seiko Sho | Melanin decomposing method and melanin decomposing substance |
| JP2004107284A (en) * | 2002-09-20 | 2004-04-08 | Naris Cosmetics Co Ltd | Cosmetic |
| WO2005026290A1 (en) * | 2003-09-10 | 2005-03-24 | Shiseido Co., Ltd. | Antioxidant, whitening agent and skin preparation for external use containing the same |
| JP4783436B2 (en) * | 2005-12-29 | 2011-09-28 | イーエルシー マネージメント エルエルシー | Extract from black yeast for skin whitening |
| JP2013133332A (en) * | 2011-12-26 | 2013-07-08 | Satoshi Shinkawa | Method for producing polysaccharide presenting melanin decomposition action |
| JP2018534351A (en) * | 2015-09-29 | 2018-11-22 | ジョンソン・アンド・ジョンソン・コンシューマー・インコーポレイテッドJohnson & Johnson Consumer Inc. | Method and composition for whitening skin using cell culture extract of Shimagatake bamboo |
-
1991
- 1991-07-12 JP JP3197264A patent/JPH06219933A/en active Pending
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU667338B2 (en) * | 1993-02-08 | 1996-03-21 | Kabushiki Kaisha Kobe Seiko Sho | Melanin decomposing method and melanin decomposing substance |
| JP2004107284A (en) * | 2002-09-20 | 2004-04-08 | Naris Cosmetics Co Ltd | Cosmetic |
| WO2005026290A1 (en) * | 2003-09-10 | 2005-03-24 | Shiseido Co., Ltd. | Antioxidant, whitening agent and skin preparation for external use containing the same |
| US7749508B2 (en) | 2003-09-10 | 2010-07-06 | Shiseido Co., Ltd. | Skin whitening method using Pleurotus nebrodensis |
| JP4783436B2 (en) * | 2005-12-29 | 2011-09-28 | イーエルシー マネージメント エルエルシー | Extract from black yeast for skin whitening |
| JP2013133332A (en) * | 2011-12-26 | 2013-07-08 | Satoshi Shinkawa | Method for producing polysaccharide presenting melanin decomposition action |
| JP2018534351A (en) * | 2015-09-29 | 2018-11-22 | ジョンソン・アンド・ジョンソン・コンシューマー・インコーポレイテッドJohnson & Johnson Consumer Inc. | Method and composition for whitening skin using cell culture extract of Shimagatake bamboo |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1638991B1 (en) | Cosmetic or dermopharmaceutical composition for reducing the signs of cutaneous ageing | |
| EP0862910B1 (en) | Use of retinoids as skin pigmentation inducing agent | |
| EP0658099B1 (en) | Anti-free-radical topical composition based on a superoxide dismutase and a phosphonic derivative | |
| EP0818200B1 (en) | Use of polysaccharide to stimulate desquamation of the skin and compositions containing it | |
| EP1430883B1 (en) | Cosmetic use of ascorbic acid derivatives as whitening agents for skin or hair | |
| WO2019016446A1 (en) | Cosmetic or pharmaceutical composition for promoting hair growth, comprising a lyophilisate of dedifferentiated sea fennel cells | |
| FR2844715A1 (en) | Cosmetic, pharmaceutical or food supplement compositions, comprising resveratrol oligomer or derivative, optionally as plant extract, useful for combating disorders of skin or exoskeleton, e.g. acne or dry skin | |
| JP2009298752A (en) | Skin care preparation composition for external use | |
| JPH0930954A (en) | Beautifying and whitening dermal preparation for external use | |
| EP0636360A1 (en) | Cosmetic composition containing an association of a superoxide dismutase and a melanin pigment | |
| JPH11246347A (en) | Preparation for external use for skin bleaching | |
| WO2020218888A1 (en) | Cosmetic composition for skin whitening containing novel lactobacillus rhamnosus lm1011 as active ingredient | |
| US5578296A (en) | Decomposition of melanin using a culture of basidiomycetes fungus | |
| WO2020111450A9 (en) | Composition for promoting bleaching of melanin | |
| JPH0812561A (en) | Beautifying and whitening skin preparation for external use | |
| JP2000344653A (en) | Eraser for active oxygen and skin cosmetic | |
| JPH0987164A (en) | External preparation for skin | |
| JP2009522308A (en) | Extract from black yeast for skin whitening | |
| JPH1029922A (en) | Preparation for external use for skin | |
| JPH08310939A (en) | Beautifying and whitening dermal preparation for external use | |
| JPH0987135A (en) | Dermal preparation for external use | |
| KR100370787B1 (en) | External skin preparation | |
| KR102737352B1 (en) | Cosmetic composition comprising asparagopsis taxiformis fermented extract using the ak1954 strain as an effective components | |
| JPH08217659A (en) | Method for decoloring mlanin | |
| JPH1029928A (en) | Skin preparation for external use |